New drug combo tested for Tough-to-Treat head and neck cancer
Disease control
Completed
This study tested a combination of two drugs, duvelisib and docetaxel, for people with advanced head and neck cancer that had returned or spread after their first treatment stopped working. The goal was to see if this new combination could help control the cancer. About 26 people…
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC